U.S Class(es): 006, 018, 044, 046, 051, 052
Class Status: Active
Name | Novartis Pharma AG, Trademark Department |
---|---|
Address | Postfach CH-4002 Basel, SWITZERLAND |
Date | Description | Action Tags | Code |
---|---|---|---|
Jun-07-2018 | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | SDRCM | |
Jun-11-2018 | LIMITATION FROM ORIGINAL APPLICATION ENTERED | LIMII | |
Jun-12-2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | NWOSI | |
Jun-16-2018 | APPLICATION FILING RECEIPT MAILED | MAFRO | |
Jun-19-2018 | ASSIGNED TO EXAMINER | DOCKD | |
Jun-19-2018 | APPROVED FOR PUB - PRINCIPAL REGISTER | CNSAO | |
Jul-04-2018 | NOTICE OF PUBLICATION | NPUBO | |
Jul-05-2018 | WITHDRAWN FROM PUB - OG REVIEW QUERY | PBCRZ | |
Aug-29-2018 | NOTICE OF PUBLICATION | NPUBO | |
Sep-05-2018 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | OP2RP | |
Sep-05-2018 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | OPNSP | |
Sep-18-2018 | PUBLISHED FOR OPPOSITION | PUBOA | |
Nov-02-2018 | NOTIFICATION PROCESSED BY IB | GPNXP | |
Dec-04-2018 | REGISTERED-PRINCIPAL REGISTER | R.PRA | |
Dec-20-2018 | CORRECTION TRANSACTION RECEIVED FROM IB | CRCVM | |
Jan-03-2019 | GRANT OF PROTECTION CREATED, TO BE SENT TO IB | GPARP | |
Jan-16-2019 | FINAL DISPOSITION PROCESSED | FIMPP | |
Jan-16-2019 | FINAL DISPOSITION NOTICE SENT TO IB | FICSP | |
Mar-01-2019 | NOTIFICATION PROCESSED BY IB | GPNXP | |
Jan-20-2022 | REQUEST TO CANCEL INADVERTENTLY ISSUED REGISTRATION RECEIVED | RCIII | |
Jan-24-2022 | ASSIGNED TO PETITION STAFF | APETA | |
Jan-26-2022 | REG. CANCELLED - RESTORED TO PENDENCY | CRTPC | |
Apr-18-2022 | CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED | CREVI | |
Apr-29-2022 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | ERRRO | |
Feb-01-2023 | ELECTRONIC RECORD REVIEW COMPLETE | FIXDO | |
Aug-20-2024 | WITHDRAWN FROM PUB - OG REVIEW QUERY | PBCRZ | |
Sep-11-2024 | NOTICE OF PUBLICATION | NPUBO | |
Oct-01-2024 | PUBLISHED FOR OPPOSITION | PUBOA | |
Dec-03-2024 | REGISTERED-PRINCIPAL REGISTER | R.PRA |